Home
Market Capitalization of Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
Market Cap
Key Highlights
- The Market Cap of Glenmark Pharmaceuticals Ltd is ₹ 36691 crore as of 21 Feb 25 .
- The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1300 as of 21 Feb 15:30 .
- The dividend payouts of Glenmark Pharmaceuticals Ltd changed from ₹ 2 to ₹ 2.5 over 6 quarters. This represents a CAGR of 16.04% .

Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
Share Price
Market Price of Glenmark Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1300.25 |
20 Feb 2025 | 1349 |
19 Feb 2025 | 1369.4 |
18 Feb 2025 | 1377.65 |
17 Feb 2025 | 1374.65 |
14 Feb 2025 | 1321.35 |
13 Feb 2025 | 1409.9 |
12 Feb 2025 | 1406.9 |
11 Feb 2025 | 1452.55 |
10 Feb 2025 | 1513.85 |
SWOT Analysis Of Glenmark Pharmaceuticals Ltd
BlinkX Score for Glenmark Pharmaceuticals Ltd
Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Glenmark Pharmaceuticals Ltd
Historical P/E Ratio of Glenmark Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Glenmark Pharmaceuticals Ltd
Historical Revenue of Glenmark Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Glenmark Pharmaceuticals Ltd
Historical EBITDA of Glenmark Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Glenmark Pharmaceuticals Ltd
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Historical Dividend Payouts of Glenmark Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Glenmark Pharmaceuticals Ltd
About Glenmark Pharmaceuticals Ltd
- Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
- The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
- It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
- Its branded generics business has a significant presence in markets across emerging economies including India.
- The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.
Glenmark Pharmaceuticals Ltd News Hub
Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1
Read more
21 Aug 24
Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session
Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163
Read more
19 Aug 24
Glenmark Pharma gains after American subsidiary launches Olopatadine generic
The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L
Read more
19 Aug 24
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio
Read more
19 Aug 24